Page last updated: 2024-08-23

lovastatin and Hyperlipoproteinemia Type III

lovastatin has been researched along with Hyperlipoproteinemia Type III in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (26.67)	18.7374
1990's	10 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (6.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Averna, M; Blom, D; Cefalù, AB; Ciccarese, M; Cossu, M; Croyal, M; Dallinga-Thie, G; Guédon, A; Hovingh, K; Lambert, G; Passard, M; Peter, J; Pintus, P; Pisciotta, L; Prampart-Fauvet, S; Raal, F; Santos, RD; Sjouke, B; Thedrez, A	1
Gylling, H; Miettinen, TA; Relas, H	1
Frants, RR; Gevers Leuven, JA; Havekes, LM; Smelt, AH; Van 't Hooft, FM; Van den Maagdenberg, AM; Van der Laarse, A; Van Tol, A; Vroom, TF; Zhao, SP	1
Göring, HD; Ziemer, A	1
Gaw, A; Wosornu, D	1
Eichinger, M; Feussner, G; Ziegler, R	1
Mol, MJ; Stalenhoef, AF; Stuyt, PM	1
Hambrecht, R; Kübler, W; Schuler, G; Tischbirek, K; von Hodenberg, E	1
MacDonald, JL; Mauro, VF	1
Illingworth, DR; O'Malley, JP	1
Demacker, PN; Mol, MJ; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A	1
Mol, MJ; Stalenhoef, AF; Stuyt, PM; van 't Laar, A	1
Illingworth, DR	1
East, C; Grundy, SM; Vega, GL	1
Bilheimer, DW; East, CA; Grundy, SM	1

Reviews

2 review(s) available for lovastatin and Hyperlipoproteinemia Type III

Article	Year
Simvastatin: a review of its pharmacology and clinical use. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:3 Topics: Adolescent; Adult; Anticholesteremic Agents; Cholesterol; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lovastatin; Simvastatin	1991
Drug therapy of hypercholesterolemia. Clinical chemistry, 1988, Volume: 34, Issue:8B Topics: Bile Acids and Salts; Cholesterol, LDL; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lovastatin; Niacin	1988

Trials

2 trial(s) available for lovastatin and Hyperlipoproteinemia Type III

Article	Year
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia. The Clinical investigator, 1992, Volume: 70, Issue:11 Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides	1992
The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia. Metabolism: clinical and experimental, 1990, Volume: 39, Issue:4 Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Time Factors; Triglycerides	1990

Article

Year

The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.

The Clinical investigator, 1992, Volume: 70, Issue:11

Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides

1992

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia.

Metabolism: clinical and experimental, 1990, Volume: 39, Issue:4

Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Time Factors; Triglycerides

1990

Other Studies

11 other study(ies) available for lovastatin and Hyperlipoproteinemia Type III

Article	Year
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Case-Control Studies; Cells, Cultured; Cholesterol, LDL; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type III; Lovastatin; Lymphocytes; Male; Middle Aged; Mutation; PCSK9 Inhibitors; Phenotype; Proprotein Convertase 9; Receptors, LDL; Serine Proteinase Inhibitors; Young Adult	2016
Postprandial vitamin A and squalene clearances and cholesterol synthesis off and on lovastatin treatment in type III hyperlipoproteinemia. Atherosclerosis, 1995, Volume: 115, Issue:1 Topics: Adult; Apolipoprotein E3; Apolipoproteins E; Cholesterol; Cholesterol, Dietary; Cohort Studies; Dietary Fats; Eating; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Metabolic Clearance Rate; Middle Aged; Phenotype; Reference Values; Squalene; Sterols; Triglycerides; Vitamin A	1995
Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin. Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:11 Topics: Adult; Aged; Apolipoprotein E2; Apolipoprotein E3; Apolipoproteins E; Carrier Proteins; Cholesterol Ester Transfer Proteins; Female; Glycoproteins; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Reference Values; Simvastatin	1994
[Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1993, Volume: 44, Issue:8 Topics: Adolescent; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Foam Cells; Homozygote; Humans; Hyperlipoproteinemia Type III; Lovastatin; Phenotype; Skin; Triglycerides	1993
Simvastatin during warfarin therapy in hyperlipoproteinaemia. Lancet (London, England), 1992, Oct-17, Volume: 340, Issue:8825 Topics: Female; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lovastatin; Middle Aged; Simvastatin; Warfarin	1992
Long-term effects of simvastatin in familial dysbetalipoproteinaemia. Journal of internal medicine, 1991, Volume: 230, Issue:2 Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type III; Lovastatin; Male; Middle Aged; Simvastatin; Time Factors; Triglycerides	1991
[Type III hyperlipoproteinemia in monoclonal IgM gammopathy]. Deutsche medizinische Wochenschrift (1946), 1991, Nov-08, Volume: 116, Issue:45 Topics: Adult; Bezafibrate; Cholesterol; Dietary Fats; Female; Humans; Hypergammaglobulinemia; Hyperlipoproteinemia Type III; Immunoglobulin lambda-Chains; Immunoglobulin M; Lipids; Lovastatin; Niacin; Triglycerides	1991
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia). The American journal of medicine, 1990, Volume: 88, Issue:1N Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides	1990
Cholesterol synthesis inhibitors in hyperlipidaemia. Lancet (London, England), 1988, Mar-12, Volume: 1, Issue:8585 Topics: Anticholesteremic Agents; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lovastatin; Male; Middle Aged; Simvastatin	1988
Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B. Atherosclerosis, 1988, Volume: 70, Issue:1-2 Topics: Adult; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Kinetics; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Pentanoic Acids; Triglycerides	1988
Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin. Metabolism: clinical and experimental, 1986, Volume: 35, Issue:2 Topics: Adult; Cholesterol; Humans; Hyperlipoproteinemia Type III; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Male; Naphthalenes; Triglycerides	1986